Libongan, Diojoria A.
HRN: 17-66-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/09/2025
11/14/2025
IV
4.5
18
Sepsis Secondary To Bacterial Skin Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Frequency
Final appropriateness: No Wrong Choice
Overall appropriateness: No